Opthea Raises A$171.5M in Placement and Entitlement Offer
Ticker: OPTEY · Form: 6-K · Filed: Jun 14, 2024 · CIK: 1815620
Sentiment: bullish
Topics: capital-raise, financing, clinical-development
TL;DR
Opthea just snagged A$171.5M to fund its drug development. Big win for their pipeline.
AI Summary
Opthea Limited announced on June 14, 2024, that it has successfully completed a placement and the institutional component of its entitlement offer, raising A$171.5 million (approximately US$113.2 million). This capital raise is intended to support the company's ongoing clinical development programs.
Why It Matters
This significant capital injection provides Opthea with the necessary funds to advance its promising therapies, potentially impacting the treatment landscape for certain eye diseases.
Risk Assessment
Risk Level: medium — While the capital raise is positive, the company is still in the clinical development phase, which inherently carries significant risks.
Key Numbers
- A$171.5M — Capital Raised (Funds secured through a placement and entitlement offer to support clinical development.)
- US$113.2M — Capital Raised (USD) (Equivalent amount raised in US dollars.)
Key Players & Entities
- Opthea Limited (company) — Registrant
- A$171.5 million (dollar_amount) — Amount raised in placement and entitlement offer
- US$113.2 million (dollar_amount) — Equivalent amount raised in US dollars
- June 14, 2024 (date) — Date of announcement
FAQ
What was the total amount raised by Opthea Limited in its recent capital raise?
Opthea Limited raised A$171.5 million (approximately US$113.2 million).
What type of capital raise did Opthea Limited complete?
Opthea Limited completed a placement and the institutional component of an entitlement offer.
When was the announcement of Opthea Limited's successful capital raise made?
The announcement was made on June 14, 2024.
What is the primary purpose of the funds raised by Opthea Limited?
The funds are intended to support the company's ongoing clinical development programs.
What is Opthea Limited's principal executive office address?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
Filing Stats: 156 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2024-06-13 19:12:07
Key Financial Figures
- $171.5 million — Component of Entitlement Offer Raising A$171.5 million (US$113.2m) SIGNATURES Pursuant to
- $113.2m — lement Offer Raising A$171.5 million (US$113.2m) SIGNATURES Pursuant to the require
Filing Documents
- opt_completes_placement_.htm (6-K) — 23KB
- opt-ex99_1.htm (EX-99.1) — 60KB
- img260626642_0.jpg (GRAPHIC) — 61KB
- img260626642_1.jpg (GRAPHIC) — 61KB
- 0000950170-24-073232.txt ( ) — 252KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 06/14/2024